Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma.
Mai 2009 - Oncol. Rep.; 21(6):1021-335X [PMID:19424640]
[Bachleitner-Hofmann T] [Friedl J] [Hassler M] [Hayden H] [Dubsky P] [Sachet M] [Rieder E] [Pfragner R] [Brostjan C] [Riss S] [Niederle B] [Gnant M] [Stift A]

Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.
Nov 2005 - Anticancer Res.; 25(6B):0250-7005 [PMID:16309220]
[Pfragner R] [Skofitsch G] [Höger H] [Jech M] [Rinner B] [Siegl V] [Niederle B] [Gnant M] [Friedl J] [Stift A]

Dendritic cell vaccination in medullary thyroid carcinoma.
Mai 2004 - Clin. Cancer Res.; 10(9):1078-0432 [PMID:15131029]
[Stift A] [Sachet M] [Yagubian R] [Bittermann C] [Dubsky P] [Brostjan C] [Pfragner R] [Niederle B] [Jakesz R] [Gnant M] [Friedl J]

Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells.
Mrz 2002 - J. Clin. Endocrinol. Metab.; 87(3):0021-972X [PMID:11889172]
[Bachleitner-Hofmann T] [Stift A] [Friedl J] [Pfragner R] [Radelbauer K] [Dubsky P] [Schüller G] [Benkö T] [Niederle B] [Brostjan C] [Jakesz R] [Gnant M]